The 37-kDa/67-kDa laminin receptor acts as a receptor for infectious prions and is inhibited by polysulfated glycanes

被引:99
作者
Gauczynski, Sabine
Nikles, Daphne
El-Gogo, Susanne
Papy-Garcia, Dulce
Rey, Clemence
Alban, Susanne
Barritault, Denis
Lasmezas, Corinne Ida
Weiss, Stefan
机构
[1] Univ Munich, Inst Biochem, Mol Biol Lab, Genzentrum, D-81377 Munich, Germany
[2] Univ Kiel, Inst Pharmaceut, Kiel, Germany
[3] Univ Paris 12, CNRS, Lab CRRET, UMR 7149, Creteil, France
[4] Scripps Florida, Scripps Res Inst, Dept Infectol, Jupiter, FL USA
关键词
D O I
10.1086/505914
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Recently, we showed that the 37-kDa/67-kDa laminin receptor (LRP/LR) acts as the receptor of the cellular prion protein. Methods. For the present study, we investigated the binding of the murine scrapie prion protein (moPrP27-30) to baby hamster kidney (BHK) cells, using the Semliki Forest virus system. Results. The enhanced binding of moPrP27-30 to BHK cells expressing moLRP::FLAG was inhibited by the LRP/LR-specific antibody W3, which suggests that LRP/LR acts as a receptor for the scrapie form of the prion protein, PrPSc. This finding was confirmed by a parallel study that showed that bovine prions are internalized by human enterocytes via LRP/LR. The heparan sulfate mimetics HM5004 and HM2602 reduced PrP27-30 binding to moLRP-expressing cells to similar to 30% and similar to 20%, respectively, at a concentration of 10 mu g/mL, whereas pentosan polysulfate (SP54) and phycarin sulfate (PS3) both reduced the binding to similar to 40% at a concentration of 100 mu g/ mL. Conclusions. We suggest that the inhibition reported elsewhere of PrPSc synthesis and the incubation times prolonged in rodent models by these sulfated glycans are due to the inhibition of the LRP/LR-dependent binding of prions to the target cells.
引用
收藏
页码:702 / 709
页数:8
相关论文
共 36 条
[1]   A novel generation of heparan sulfate mimetics for the treatment of prion diseases [J].
Adjou, KT ;
Simoneau, S ;
Salès, N ;
Lamoury, F ;
Dormont, D ;
Papy-Garcia, D ;
Barritault, D ;
Deslys, JP ;
Lasmézas, CI .
JOURNAL OF GENERAL VIROLOGY, 2003, 84 :2595-2603
[2]   MS-8209, A NEW AMPHOTERICIN-B DERIVATIVE, PROVIDES ENHANCED EFFICACY IN DELAYING HAMSTER SCRAPIE [J].
ADJOU, KT ;
DEMAIMAY, R ;
LASMEZAS, C ;
DESLYS, JP ;
SEMAN, M ;
DORMONT, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (12) :2810-2812
[3]   Prion diseases [J].
Aguzzi, A ;
Weissmann, C .
HAEMOPHILIA, 1998, 4 (04) :619-627
[4]   Spongiform encephalopathies - B lymphocytes and neuroinvasion [J].
Brown, P .
NATURE, 1997, 390 (6661) :662-663
[5]   MICE DEVOID OF PRP ARE RESISTANT TO SCRAPIE [J].
BUELER, H ;
AGUZZI, A ;
SAILER, A ;
GREINER, RA ;
AUTENRIED, P ;
AGUET, M ;
WEISSMANN, C .
CELL, 1993, 73 (07) :1339-1347
[6]   Specific inhibition of pathological prion protein accumulation by small interfering RNAs [J].
Daude, N ;
Marella, M ;
Chabry, J .
JOURNAL OF CELL SCIENCE, 2003, 116 (13) :2775-2779
[7]   CHEMOPROPHYLAXIS OF SCRAPIE IN MICE [J].
DIRINGER, H ;
EHLERS, B .
JOURNAL OF GENERAL VIROLOGY, 1991, 72 :457-460
[8]   Prophylactic potential of pentosan polysulphate in transmissible spongiform encephalopathies [J].
Farquhar, C ;
Dickinson, A ;
Bruce, M .
LANCET, 1999, 353 (9147) :117-117
[9]   Recombinant human prion protein mutants huPrP D178N/M129 (FFI) and huPrP+9OR (fCJD) reveal proteinase K resistance [J].
Gauczynski, S ;
Krasemann, S ;
Bodemer, W ;
Weiss, S .
JOURNAL OF CELL SCIENCE, 2002, 115 (21) :4025-4036
[10]   The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein [J].
Gauczynski, S ;
Peyrin, JM ;
Haïk, S ;
Leucht, C ;
Hundt, C ;
Rieger, R ;
Krasemann, S ;
Deslys, JP ;
Dormont, D ;
Lasmézas, CI ;
Weiss, S .
EMBO JOURNAL, 2001, 20 (21) :5863-5875